Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (7) | Back to Search
HPS-036 - Pharmacy and oncology clinic hazardous neoplastic drugs surface contamination testing in Canadian hospitals
- At: Copenhagen (Denmark) (2025)
- Type: Poster
- Poster code: HPS-036
- By: VAILLANCOURT, Régis (Quess 360-Pharmacy Solution, Canada)
- Co-author(s): Dr Régis Vaillancourt (Quess 360-Pharmacy Solution, Ottawa, Canada)
Thierry Desjarsin (DAXX Group, Canada)
Pharmacy assistant Carl Nikolaidis (Quess 360-Pharmacy Solution, Ottawa, Canada) - Abstract:
Introduction: Exposure of health care workers to hazardous drugs can lead to negative health effects. Guidelines recommend the safe handling of neoplastic drugs and regular surface sampling as contributing to worker safety. The results of routine samplings in several Canadian centers were compiled to determine the locations most likely to be..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 September 2025